Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23
Closed -$1.74K 833
2026
Q1
$1.74K Buy
23
+12
+109% +$902 ﹤0.01% 790
2025
Q4
$819 Buy
+11
New +$804 ﹤0.01% 430
2025
Q3
Sell
-34
Closed -$2.21K 692
2025
Q2
$2.21K Sell
34
-138
-80% -$8.27K ﹤0.01% 857
2025
Q1
$2.35K Buy
172
+134
+353% +$8.88K ﹤0.01% 857
2024
Q4
$2.74K Buy
+38
New +$2.97K ﹤0.01% 817

Other funds holding HOLX

Whipplewood Advisors's HOLX Position: Q2 2026 in Review

Whipplewood Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 23 shares — an estimated $1.74K sold.

Whipplewood Advisors first reported a position in HOLX in Q4 2024 and held it in 5 quarters. The position peaked at $2.74K in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Whipplewood Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Whipplewood Advisors sold 23 Hologic shares in Q2 2026, an estimated $1.74K.
  • Whipplewood Advisors first reported a position in Hologic in Q4 2024 and held it in 5 quarters.
  • Whipplewood Advisors's Hologic position peaked at $2.74K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.